ArticleBlood advances2019

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study.

Allison Barraclough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.